Estimates Revisions Elicio Therapeutics, Inc.
Stocks
ELTX
US28657F1030
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.040 USD | -2.25% |
|
-7.60% | -61.81% |
| 07-06 | Elicio Therapeutics Closes $15 Million Registered Direct Offering | MT |
| 07-02 | Top Midday Decliners | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- ELTX Stock
- Consensus Elicio Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
